Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 25, 2015 2:09 PM ET


Company Overview of Ultragenyx Pharmaceutical Inc.

Executive Profile

Eric W. Linsley CPA, MBA

AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 15 different industries.

See Board Relationships


Mr. Eric W. Linsley, CPA, MBA, is a Managing Partner at Pappas Ventures. Prior to joining the firm in 2000, he served as the Chief Financial Officer and Vice President of TriPath Imaging Inc. Mr. Linsley played a key role in the three-way merger between AutoCyte, NeoPath and Neuromedical Systems that created TriPath. Prior to the merger, he served as the Chief Financial Officer and Vice President of Operations at AutoCyte, where Mr. Linsley led it in a successful public ...

Corporate Headquarters

60 Leveroni Court
Novato, California 94949

United States

Phone: 415-483-8800
Fax: 415-483-8810

Board Members Memberships

Former Director
Chairperson and Member of Executive Committee
Former Director
Former Director
Former Director and Member of Compensation Committee
Director, Chairman of Audit Committee and Member of Compensation, Nomination & Governance Committee


New York University
University of Pennsylvania - The Wharton School
Trinity College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ultragenyx Pharmaceutical Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at